Rottlerin is a mitochondrial uncoupler that decreases cellular ATP levels and indirectly blocks protein kinase Cdelta

S P Soltoff1

  • 1Division of Signal Transduction, Harvard Institutes of Medicine, Boston, Massachusetts 02215, USA. ssoltoff@caregroup.harvard.edu

Insights

Rottlerin, previously thought to inhibit PKCdelta, actually uncouples mitochondrial respiration. This finding impacts studies using rottlerin, suggesting caution in interpreting results related to mitochondrial function and protein kinase Cdelta signaling.

Area of Science:

  • Biochemistry
  • Cell Biology
  • Mitochondrial Physiology

Background:

  • Protein kinase Cdelta (PKCdelta) activation involves tyrosine phosphorylation and regulates fluid secretion in salivary gland cells.
  • Rottlerin is a commonly used compound reported as a selective inhibitor of PKCdelta.

Purpose of the Study:

  • To investigate the mechanism of action of rottlerin on cellular respiration and PKCdelta activity.
  • To determine if rottlerin directly affects PKCdelta or has off-target effects on mitochondrial function.

Main Methods:

  • Measured oxygen consumption (QO2) in parotid acinar cells, PC12 cells, and isolated rat liver mitochondria.
  • Assessed the effects of rottlerin, carbachol, GF109203X, and FCCP on QO2 and cellular ATP levels.
  • Evaluated PKCdelta tyrosine phosphorylation in response to rottlerin and FCCP.

Main Results:

  • Rottlerin increased QO2 in parotid cells and isolated mitochondria, similar to uncouplers like FCCP.
  • Rottlerin's effects on mitochondrial QO2 were independent of PKC inhibition and did not mimic or block PKC inhibitors.
  • Rottlerin and FCCP reduced cellular ATP and PKCdelta tyrosine phosphorylation in oxidative phosphorylation-dependent cells.

Conclusions:

  • Rottlerin directly uncouples mitochondrial respiration from oxidative phosphorylation.
  • Previous research utilizing rottlerin requires cautious re-evaluation due to its direct mitochondrial effects.
  • Rottlerin is not a selective PKCdelta inhibitor and its cellular effects are primarily mediated by mitochondrial uncoupling.

Related Concept Videos

Electron Transport Chain: Complex I and II01:46

Electron Transport Chain: Complex I and II

The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
Receptor Tyrosine Kinases01:26

Receptor Tyrosine Kinases

Receptor tyrosine kinases or RTKs are membrane-bound receptors that phosphorylate specific tyrosine on protein substrates. RTKs regulate cellular growth, differentiation, survival, and migration. They contain an extracellular ligand binding domain, a transmembrane domain, and a cytosolic tail with intrinsic kinase activity. Several extracellular signaling molecules activate RTKs in one or more ways and relay the signal downstream. Ligands such as platelet-derived growth factor (PDGF) or...
MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...
Directly Acting Muscle Relaxants: Dantrolene and Botulinum Toxin01:26

Directly Acting Muscle Relaxants: Dantrolene and Botulinum Toxin

Directly acting muscle relaxants like dantrolene and botulinum toxin (BoNT) have distinct mechanisms and applications. Dantrolene, a hydantoin derivative, acts on the ryanodine receptor (RYR1) in skeletal muscle cells. RYR1 are calcium channels present at the sarcoplasmic reticulum membrane. In response to excitation, they release calcium ions from the sarcoplasmic reticulum to the cytosol. Calcium promotes actin-myosin-mediated contraction of muscles.
The binding of dantrolene to the RYR1...